Dr Cherian Thampy

Consultant Medical Oncology

Specialty: Oncology

Practice Locations: NMC Specialty Hospital, Abu Dhabi

Dr. Cherian joins NMC with 8 years’ experience in Oncology from the prestigious KIMS - Cancer Center in Trivandrum, India where he was working as Associate Consultant in Medical Oncology since 2015. Prior to KIMS, Dr. Cherian was working at the world renowned Cancer Institute, Chennai, India as an Assistant Professor of Medical Oncology.



He has also worked at SRMC, Chennai, India and Lakeshore Hospital, Kochi, India.



Dr. Cherian Thampy completed MBBS from K.S. Hegde Medical Academy, Mangalore and thereafter obtained his MD in General Medicine from Sri Ramachandra Medical College, Chennai. He went on to complete his DM in Medical Oncology from The Cancer Institute, Chennai, India. Dr. Cherian Thampy successfully completed his MRCP Speciality certification in medical oncology. It is certified by the federation of royal college of physicians of United Kingdom and the association of cancer physicians.



Dr. Cherian Thampy key areas of interest are:




  • Gastrointestinal Oncology

  • Lymphomas

  • Breast Cancers

  • Immunotherapy



During his MD in General Medicine at Sri Ramachandra Medical College, Dr. Cherian was a Gold Medal Scholar. Dr. Cherian Thampy also was part of the team that setup the Autologous Bone Marrow Transplant Unit and the Paediatric Bone Marrow Transplant program at the KIMS Cancer Centre, Trivandrum, India.



Dr. Cherian Thampy has presented and attended various international and national Oncology conferences.



He speaks English, Malayalam, Tamil and Hindi.


Practice Locations

NMC Specialty Hospital, Abu Dhabi
NMC Specialty Hospital, Abu Dhabi

Zayed the First St., Near Sama Tower, Madinat Zayed, P.O. Box: 6222, Abu Dhabi, United Arab Emirates.

NMC uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy